SUPPLEMENTAL FIGURE LEGENDS
(G) After electroporation of control-mo or anosmin-mo into HH4 + embryos, the embryos were cultured another 10 to 11 hours until HH8-9. They were then cryostat sectioned, and TUNEL-labeled cells per section in the cranial neural fold were counted (control n=5 embryos, anosmin n=6 embryos).
(H and I) Electroporation of control-mo or anosmin-mo was performed at HH4 + , and the embryos were cultured another 10 to 11 hours until HH8-9. For rescue experiments, 7 hours after electroporation, 2.75 g/ml purified anosmin protein in 0.1% BSA/Hank's BSS was injected into the cranial regions of HH7
The embryos were cultured for another 4 hours until HH8-9. Cranial neural folds of control-mo, anosmin-mo, and anosmin-mo plus anosmin protein embryos were dissected (n=3-4 embryos each), and total RNA was used for qPCR. SNAI2 (H),
, and SOX9 (data not shown) expression levels were deceased 40 to 50% in the anosmin knock-down neural folds, but injection of purified anosmin protein rescued levels to within 90% of control levels (H and I). Data are shown as means and SEM. *p < 0.0001. (E-G) Anosmin, FGF8, and BMP5 expression characterized by whole-mount in situ hybridization. Anosmin expression spanned the entire cranial neural fold from forebrain to midbrain (E, black and white arrowheads, also see Fig 2F and H). FGF8 was expressed strongly in forebrain neural fold (F, white arrowheads) and midbrain neural tube and neural fold (F, black arrowheads). BMP5 was expressed strongly in midbrain neural fold (G, black arrowheads), and was not expressed in forebrain neural fold (G, white arrowheads). Scale bar, 200 m.
(H and H') Recombinant FGF8 (2 μg/ml) and BMP5 (10 μg/ml) proteins were injected into one side of the cranial region of HH7 + embryos (red asterisk). The embryos were cultured for 6 hours and then examined for SNAI2 expression by in situ hybridization (H and H'). SNAI2 expression was inhibited (4 out of 10) or unchanged (6/10). Scale bar, 200 m. (I) Recombinant FGF8 (2 μg/ml), BMP5
(10 μg/ml), or BSA (1 mg/ml) as a control, all in 0.1% BSA/Hank's BSS, were injected into both sides of the cranial regions of HH7+ embryos, and the embryos were cultured for 6 hours until HH8-9. Cranial neural folds were dissected (n=4-6 embryos each), and total RNA was used for qPCR. SNAI2 expression levels were severely decreased in FGF8 plus BMP5 injected embryos, while either Mc, Meckel's cartilage; bb, basibranchial; bh, basihyal; cb, ceratobranchial; eb, epibranchial; q, quadrate; ra, retroarticular process. Scale bar, 1 mm.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Reverse transcription and quantitative PCR
Reverse transcriptase Superscript , , and VILO (Invitrogen) were used for cDNA synthesis according to the manufacturer's protocol. Reverse transcription PCR (RT-PCR) was performed using ExTaq DNA polymerase (Takara) to confirm microarray data using a GeneAmp PCR system 9700 (Applied Biosystems; data not shown). Quantitative PCR (qPCR) was performed using After restriction enzyme (Roche) linearization of the cDNA plasmids, digoxigeninlabeled antisense and sense RNA probes were synthesized by SP6, T7 or T3 polymerases (Roche).
In situ hybridization
In situ hybridization was performed on frozen sections and in whole-mounts as for anosmin, anti-mouse IgG-cy3 (Jackson) for SNAI2, and anti-rabbit-FITC (Jackson) for fibronectin. Stained whole embryos and sections were imaged on using a Stemi SV11 microscope or Axiophot and Confocal 510 microscopes (Zeiss), respectively, and images were adjusted using Photoshop 7.0.
Anosmin antibody production
Rabbit immune sera were produced ( (HL6158) and FNIII-2/3 (HL6157) polyclonal antibodies were subsequently purified by affinity chromatography using the corresponding synthetic peptide conjugated to a SulfoLink column (Pierce). Antibody specificity was verified using mammalian cells over-expressing recombinant chicken anosmin protein (data not shown) or lysates of E8 chicken kidney by western blotting ( Figure S1 ).
Anosmin protein purification
Full-length chicken anosmin cDNA was generated by RT-PCR from HH8 embryo cDNA and was subcloned for initial experiments into the pEF6 / V5-His expression vector (Invitrogen), and the full sequence was confirmed. Chicken anosmin in pEF6 / V5-His was digested with BamH I and Pme I, and anosmin-V5-His was inserted by blunt-end ligation into the Xho I site of the pCAGGS vector (Momose et al., 1999) . These anosmin expression vectors were used for overexpression in vivo and in vitro (data not shown). Because initial experiments indicated that anosmin function could be affected by a fusion protein tag such as GST, we generated tag-free recombinant anosmin protein using the pMsecSUMOstar vector (LifeSensors). Full-length chicken anosmin cDNA without the signal peptide sequence (MVSERAPGASLALLLWVTAVSG) was subcloned into BsmB I and Xho I sites of the SUMO vector (pM-sec-SUMOstar-anosmin).
Then, sec-SUMOstar-anosmin was sub-cloned from pM to the pCAGGS vector 
ELISA assay
Enzyme-linked immunosorbent assay (ELISA) was performed in 96-well plates (Immulon-2HB, Thermo). Wells were coated with 0 to 0.5 g of FGF8, FGFR1, BMP2, BMP4, BMP5, BMP7, or WNT3a in 100 l of PBS overnight at RT, and the wells were blocked with 1% BSA/PBS for 1 hour at RT. Then, 0 to 5.0 g of purified anosmin in blocking buffer was added and incubated for 2 hours at RT, followed by rinsing with TBST. Anti-anosmin antibodies (HL6157 or HL6308, 1:500) were added and incubated for 1 hour at RT, respectively. After rinsing, anti-rabbit-HRP antibody (1:500) was incubated for 1 hour at RT in the same blocking buffer, and after incubation with the enzyme substrate (TMB-ELISA, Pierce), the reaction was stopped by 1 M H 2 SO 4 , and absorbance at 450 nm was measured by a plate reader (SAFIRE, TECAN).
Anosmin protein injection
Purified anosmin protein (0.5 to 1.0 mg/ml) or 0.01% dialyzed BSA (Sigma) as a control were injected into cranial regions of HH8 -embryos. The embryos were allowed to develop until HH 9 for 5-6 hours in whole-embryo culture and examined by immunostaining or in situ hybridization. To test for anosmin regulatory effects on craniofacial morphology, heparin beads (Sigma) soaked in purified protein (2 to 500 g/ml) were implanted into the cranial region of HH9 -embryos in ovo, and the eggs were incubated for 3 days to HH23 or for 8 days to HH35. After fixation in 4% PFA/PBS at 4 o C overnight, they were used for wholemount in situ hybridization for FGF8 or stained with alcian blue to visualize Meckel's cartilage.
Alcian blue staining of cartilage
Alcian blue staining was performed as described previously with minor modifications (Dingerkus and Uhler, 1977) . Briefly, after fixation in 10% formalin overnight, embryos were washed in H 2 O and dehydrated in 75% ethanol. Then, the embryos were stained by 0.01% alcian blue 8GN (Sigma) / 20% glacial acetic acid in 75% ethanol overnight. After re-hydration in H 2 O, the samples were placed in an enzyme solution containing 30% saturated aqueous sodium borate (Sigma) and 0.1% trypsin (GIBCO). The solution was changed once or twice for 3-5 days until the cartilage was clearly visible, and specimens were stored in glycerol. Stained samples were imaged on a Zeiss Stemi SV11 dissecting microscope, and images were adjusted for brightness and contrast using Photoshop 7.0.
